Biomerica Inc
NASDAQ:BMRA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Guangdong Kitech New Material Holding Co Ltd
SZSE:300995
|
CN |
|
H
|
Hwaxin Environmental Co Ltd
SZSE:301265
|
CN |
Biomerica Inc
Total Receivables
Biomerica Inc
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Biomerica Inc
NASDAQ:BMRA
|
Total Receivables
$947k
|
CAGR 3-Years
4%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-2%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Total Receivables
$2.9B
|
CAGR 3-Years
14%
|
CAGR 5-Years
14%
|
CAGR 10-Years
9%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Total Receivables
$912.1m
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Stryker Corp
NYSE:SYK
|
Total Receivables
$4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Total Receivables
$7.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
5%
|
CAGR 10-Years
9%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Total Receivables
$1.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
19%
|
CAGR 10-Years
15%
|
|
Biomerica Inc
Glance View
Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company is headquartered in Irvine, California and currently employs 49 full-time employees. The firm develops, patents, manufactures and markets diagnostic and therapeutic products for the early detection and monitoring of chronic diseases and other medical conditions. The firm's diagnostic test kits are used to analyze blood, urine, or fecal samples from patients in the diagnosis of various diseases and other medical complications, by measuring or detecting the of specific bacteria, hormones, antibodies, antigens, or other substances, in a patient body, stools, or blood, saliva or nasal fluid. The firm is engaged in research and development of disruptive, patented diagnostic guided therapy (DGT) products to treat gastrointestinal diseases, such as irritable bowel syndrome (IBS), and other inflammatory diseases.
See Also
What is Biomerica Inc's Total Receivables?
Total Receivables
947k
USD
Based on the financial report for Nov 30, 2025, Biomerica Inc's Total Receivables amounts to 947k USD.
What is Biomerica Inc's Total Receivables growth rate?
Total Receivables CAGR 10Y
-2%
Over the last year, the Total Receivables growth was -29%. The average annual Total Receivables growth rates for Biomerica Inc have been 4% over the past three years , -10% over the past five years , and -2% over the past ten years .
